Sepsivac® wins ‘Excellence in Packaging Design’ award at India Packaging Awards

Ahmedabad, September 18, 2020: Cadila Pharmaceuticals’ latest innovation for Sepsis treatment, Sepsivac®, recently won the India Packaging Award under the category ‘Excellence in Packaging Design – Graphics and Brand Value Add’ for its innovative design.

The event saw the participation from eminent pharma professionals celebrating the innovations in the packaging in the pharmaceutical sector. In ‘India Packaging Awards’, Cadila Pharmaceuticals’ Sepsivac® was given the ‘Excellence in Packaging Design – Graphics and Brand Value Add‘ award for its innovative packaging. The key features of the packaging involved infographics on the box for drug adherence, temperature indicator to provide cumulative heat exposure through the shelf life, validated cold chain boxes to ensure temperature controlled supply chain and a QR code on the package for ease of access of the e-leaflet of the product.

“We are extremely proud to have won this award, as Sepsivac® is one of the latest innovation by Cadila Pharmaceuticals in the Treatment of Sepsis. The focus on the packaging of Sepsivac® was to ensure that the medical practitioners can have complete information about the product and the quality of the product is not compromised with at all times. Through this compact, sustainable and recyclable packaging, we were able to achieve this and continue to serve the needs of the nation in an innovative way” shared Mr. O. P. Singh, President – Sales and Marketing, Cadila Pharmaceuticals Ltd.

Cadila Pharmaceuticals’ Atul Mulay, GM, Packaging Development, was also recognized as the winner of the social media campaign, #SafePackagingChallenge, organized by the global Ambassador of the World Packaging Organisation, Mr. AVPS Chakravarthi. This was awarded to Mr. Atul Mulay for his post on LinkedIn talking about the product highlights of Sepsivac®, for being the most engaged post in the challenge.

Over the year, Cadila Pharmaceuticals Ltd. has been continuously recognized for its all-around efforts to support the community, patient education and coming out with quality medicines. Cadila Pharma’s Sepsivac® was recently awarded the Covid-19 Pharma Excellence Award for being one of the most promising drugs in the fight against COVID-19 organized by HEAL Health Connect Solutions. Cadila Pharma was recently also awarded the Healthcare Crusaders Award – COVID-19 edition organized by Healthwire Media, for its extraordinary support to the community during this pandemic.

Cadila Pharmaceuticals Ltd. (www.cadilapharma.com) is one of the largest privately-held pharmaceutical companies of India. It has recently concluded and cleared USFDA inspection successfully in February 2020. Over the past six decades, Cadila Pharmaceuticals has been engaged in development and manufacturing of affordable medicines and in making them available for patients across the world. Its innovation-driven drug discovery processes ensure the health and well-being of people around the world.

Corporate  Comm India (CCI Newswire)